Monday, 12 Apr 2021 07:17 AM MYT
The study by Tel Aviv University and Clalit Health Services, Israel’s largest healthcare provider, compared 400 unvaccinated people infected with Covid-19 to 400 partially or fully vaccinated people who also had the virus. “This means that the Pfizer-BioNtech vaccine, though highly protective, probably does not provide the same level of protection against the South African variant of the coronavirus,” the study added.
“Since we found a very small number of vaccinees infected with B.1.351, it is statistically meaningless to report disease outcomes,” he said.conducted by principal vaccine manufacturers Pfizer/BioNTech and Moderna showed that the presence of antibodies after vaccination was less pronounced in people exposed to the South African variant, indicating diminished protection.
An earlier study by Clalit on 1.2 million Israelis found that the Pfizer/BioNTech jab gave 94 per cent protection against Covid-19.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.